P
Perfint Healthcare
Image-guided medical devices for oncology
About Perfint Healthcare
Perfint Healthcare specializes in developing advanced planning and targeting solutions for image-guided interventional procedures. The company operates in the medical technology market, focusing on providing tools that enhance the precision and efficiency of procedures such as tumor ablation and biopsies. Perfint Healthcare's core products include MAXIO, a physician-controlled stereotactic accessory for CT systems, ROBIO EX, a robotic positioning system for CT and PET-CT guided interventions, and NAVIOS, a workflow assistance solution for CT-guided procedures. These products are designed to assist healthcare professionals in achieving faster and more accurate results, thereby improving patient outcomes. Perfint Healthcare serves hospitals, clinics, and medical research institutions globally. The company generates revenue through the sale of its medical devices and related software solutions, as well as through ongoing service and maintenance contracts.
Source: Dealroom company dataNews
Open roles
Perfint Healthcare in the Chennai ecosystem
The Perfint Healthcare office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
Norwest Venture Partners
Chiratae Ventures
Accel
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Perfint Healthcare on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Perfint Healthcare on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

